← FDA DRUG APPROVALS

FDA ANDA · ANDA202916

MOXIFLOXACIN HYDROCHLORIDE

Sponsor: EPIC PHARMA LLC

APPLICATION
ANDA202916
TYPE
ANDA
ORIGINAL APPROVAL
2017-11-09
LATEST ACTION
2021-11-16
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued

Products

MOXIFLOXACIN HYDROCHLORIDEDiscontinued
MOXIFLOXACIN HYDROCHLORIDE EQ 0.5% BASE · SOLUTION/DROPS · OPHTHALMIC

Approval history

2021-11-16Labeling · Supplement 1 · standardAP
2017-11-09UNKNOWN · OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →